Oral medicines containing almitrine, once a go-to therapy for chronic respiratory failure in several European countries, will be withdrawn there because the drug's benefits no longer outweigh the risk ...

European Union (EU) drug regulators yesterday recommended withdrawing oral almitrine-containing medicines from the market because their benefits in managing chronic obstructive pulmonary disease (COPD ...

Almitrine is a piperazine derivative known to stimulate breathing in the adult but cause apnea in fetal sheep. In fetal sheep (127-133 d gestation; term = 147 d) we confirmed this finding, but found ...

Scientists are looking for new ways to treat toxoplasmosis, an infectious disease that affects more than a third of the world population. One of the most recent advances is reported in an article ...